Graphene-Based Devices Face Regulation Questions In Europe
Executive Summary
Medtech Insight spoke to two CEOs of start-ups working on graphene-based devices to learn more about how regulation and fears over nanomaterials’ side effects affect device development.
You may also be interested in...
Start-Up Spotlight: Grapheal Unlocking Graphene’s Potential In Wound Healing
The company has developed a biosensor that provides information to health care professionals concerning the health of a patient’s wound.
Merck Jumps On Neurostim Technology, Signing Agreements With Start-Ups
The biotech giant signed a commercial agreement with bioelectronics company Innervia, and the two will work collaboratively on vagus nerve stimulating technologies.
Startup Spotlight: INBRAIN Hopes To Leapfrog Brain Electrode Competition
By utilizing the properties of graphene, INBRAIN hopes to develop improved electrodes implanted in the brain, raising the potential of neuromodulation for treating complex neurological disorders.